98 related articles for article (PubMed ID: 15026875)
1. Effects of AT1 receptor antagonist losartan on sICAM-1 and TNF-alpha levels in uncomplicated hypertensive patients.
Sardo MA; Castaldo M; Cinquegrani M; Bonaiuto M; Fontana L; Campo S; Campo GM; Altavilla D; Saitta A
Angiology; 2004; 55(2):195-203. PubMed ID: 15026875
[TBL] [Abstract][Full Text] [Related]
2. Barnidipine compared to lercanidipine in addition to losartan on endothelial damage and oxidative stress parameters in patients with hypertension and type 2 diabetes mellitus.
Derosa G; Mugellini A; Pesce RM; D'Angelo A; Maffioli P
BMC Cardiovasc Disord; 2016 Apr; 16():66. PubMed ID: 27068332
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of tumor necrosis factor-alpha, soluble intercellular adhesion molecule-1, soluble vascular cell adhesion molecule-1, and soluble interleukin-1 receptor antagonist in patients with thyroid eye disease undergoing treatment with somatostatin analogues.
Krassas GE; Pontikides N; Doukidis D; Heufelder G; Heufelder AE
Thyroid; 2001 Dec; 11(12):1115-22. PubMed ID: 12186498
[TBL] [Abstract][Full Text] [Related]
4. Effects of an angiotensin II receptor blocker on the impaired function of endothelial progenitor cells in patients with essential hypertension.
Suzuki R; Fukuda N; Katakawa M; Tsunemi A; Tahira Y; Matsumoto T; Ueno T; Soma M
Am J Hypertens; 2014 May; 27(5):695-701. PubMed ID: 24200748
[TBL] [Abstract][Full Text] [Related]
5. [Relation of serum levels of the soluble cytoadhesion molecules sVCAM-1 and sICAM-1 to selected factors in the cytokine network in multiple myeloma].
Scudla V; Budíková M; Bacovský J; Opíchalová D; Farbiaková V
Cas Lek Cesk; 2000 Jul; 139(13):401-6. PubMed ID: 10971970
[TBL] [Abstract][Full Text] [Related]
6. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
Lacourcière Y; Neutel JM; Schumacher H
Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
[TBL] [Abstract][Full Text] [Related]
7. [Angiotensin-II receptor inhibitors in hemodialysed uremia patients with arterial hypertension: candesartan cilexitil versus losartan].
Cice G; Ferrara L; Tagliamonte E; Russo PE; Di Benedetto A; Iacono A
Cardiologia; 1999 Dec; 44(12):1071-6. PubMed ID: 10687258
[TBL] [Abstract][Full Text] [Related]
8. Effects of losartan versus hydrochlorothiazide on indices of endothelial damage/dysfunction, angiogenesis and tissue factor in essential hypertension.
Chung NA; Beevers DG; Lip G
Blood Press; 2004; 13(3):183-9. PubMed ID: 15223728
[TBL] [Abstract][Full Text] [Related]
9. Effects of a low-dose antihypertensive diuretic in combination with losartan, telmisartan, or candesartan on serum urate levels in hypertensive patients.
Hamada T; Mizuta E; Kondo T; Hirai M; Yamada K; Kato M; Shigemasa C; Yamamoto Y; Ninomiya H; Igawa O; Hisatome I
Arzneimittelforschung; 2010; 60(2):71-5. PubMed ID: 20329654
[TBL] [Abstract][Full Text] [Related]
10. Effects of the angiotensin II receptor blocker losartan on the monocyte expression of biglycan in hypertensive patients.
Sardo MA; Mandraffino G; Riggio S; D'Ascola A; Alibrandi A; Saitta C; Imbalzano E; Castaldo M; Cinquegrani M; Saitta A
Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):933-8. PubMed ID: 20497421
[TBL] [Abstract][Full Text] [Related]
11. sICAM-1 and TNF-α in asthma and rhinitis: relationship with the presence of atopy.
Ciebiada M; Gorska-Ciebiada M; Gorski P
J Asthma; 2011 Sep; 48(7):660-6. PubMed ID: 21838623
[TBL] [Abstract][Full Text] [Related]
12. The effect of losartan and amlodipine on serum adiponectin in Japanese adults with essential hypertension.
Watanabe S; Okura T; Kurata M; Irita J; Manabe S; Miyoshi K; Fukuoka T; Murakami K; Higaki J
Clin Ther; 2006 Oct; 28(10):1677-85. PubMed ID: 17157123
[TBL] [Abstract][Full Text] [Related]
13. Effects of angiotensin II-receptor blockers on soluble cell adhesion molecule levels in uncomplicated systemic hypertension: An observational, controlled pilot study in Taiwanese adults.
Hwang YS; Tsai WC; Lu YH; Lin CC; Tsai KY
Curr Ther Res Clin Exp; 2005 May; 66(3):181-94. PubMed ID: 24672122
[TBL] [Abstract][Full Text] [Related]
14. Effect of angiotensin II type 1 (AT1) receptor antagonist on the endothelial dysfunction in spontaneously hypertensive rats in correlation with the nitric oxide system.
Slaninka-Miceska M; Bogdanska J; Korneti P; Kostova E; Jovanoska E; Petrov S
Bratisl Lek Listy; 2003; 104(11):342-6. PubMed ID: 15055718
[TBL] [Abstract][Full Text] [Related]
15. Intercellular adhesion molecule 1 and tumor necrosis factor alpha in asthma and persistent allergic rhinitis: relationship with disease severity.
Gorska-Ciebiada M; Ciebiada M; Gorska MM; Gorski P; Grzelewska-Rzymowska I
Ann Allergy Asthma Immunol; 2006 Jul; 97(1):66-72. PubMed ID: 16892784
[TBL] [Abstract][Full Text] [Related]
16. Effects of enalapril and losartan on circulating adhesion molecules and monocyte chemotactic protein-1.
Jilma B; Li-Saw-Hee FL; Wagner OF; Beevers DG; Lip GY
Clin Sci (Lond); 2002 Aug; 103(2):131-6. PubMed ID: 12149103
[TBL] [Abstract][Full Text] [Related]
17. Changes of plasma endothelin and growth factor levels, and of left ventricular mass, after chronic AT1-receptor blockade in human hypertension.
Cottone S; Vadalà A; Vella MC; Nardi E; Mulé G; Contorno A; Riccobene R; Cerasola G
Am J Hypertens; 1998 May; 11(5):548-53. PubMed ID: 9633790
[TBL] [Abstract][Full Text] [Related]
18. Improved insulin sensitivity with the angiotensin II-receptor blocker losartan in patients with hypertension and other cardiovascular risk factors.
Aksnes TA; Reims HM; Guptha S; Moan A; Os I; Kjeldsen SE
J Hum Hypertens; 2006 Nov; 20(11):860-6. PubMed ID: 16988754
[TBL] [Abstract][Full Text] [Related]
19. Effect of combination therapy with the angiotensin receptor blocker losartan plus hydrochlorothiazide on brain perfusion in patients with both hypertension and cerebral hemodynamic impairment due to symptomatic chronic major cerebral artery steno-occlusive disease: a SPECT study.
Saura H; Ogasawara K; Suzuki T; Kuroda H; Yamashita T; Kobayashi M; Terasaki K; Ogawa A
Cerebrovasc Dis; 2012; 33(4):354-61. PubMed ID: 22433127
[TBL] [Abstract][Full Text] [Related]
20. Effects of angiotensin II receptor blockade-based therapy with losartan on left ventricular hypertrophy and geometry in previously treated hypertensive patients.
Cuspidi C; Meani S; Valerio C; Fusi V; Sala C; Maisaidi M; Zanchetti A
Blood Press; 2006; 15(2):107-15. PubMed ID: 16754274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
